Summary
Clarient Inc (Clarient) is a cancer diagnostic laboratory services provider that provides comprehensive cancer–diagnostic laboratory services. The company provides oncology testing and other diagnostics services. Clarient offers detailed information to characterize and assess cancer for accurate diagnosis and effective treatment. The company offers its services to oncologists, pathologists, hospitals and bio-pharmaceutical companies. Clarient focuses on the most common types of solid tumors such as breast, prostate, lung and colon tumors. The company also develops new, proprietary companion diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/ lymphoma. It is a wholly-owned subsidiary of GE Healthcare Ltd. Clarient is headquartered in Aliso Viejo in California, the US.
Clarient Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Clarient Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Clarient Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Clarient Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Clarient Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Clarient Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Clarient Inc, Medical Equipment, Deal Details 10
Partnerships 10
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 10
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 10
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 11
Biocept Enters Into Co-Marketing Agreement With Clarient 12
CombiMatrix Enters Into An Agreement With Clarient 13
Acquisition 14
NeoGenomics Acquires Clarient from GE Healthcare 14
GE Healthcare Completes Acquisition Of Clarient 16
Clarient Inc - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Clarient Inc, Medical Equipment, Key Facts 1
Clarient Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Clarient Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Clarient Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Clarient Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Clarient Inc, Deals By Market, 2011 to YTD 2017 8
Clarient Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 10
Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 10
Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 11
Biocept Enters Into Co-Marketing Agreement With Clarient 12
CombiMatrix Enters Into An Agreement With Clarient 13
NeoGenomics Acquires Clarient from GE Healthcare 14
GE Healthcare Completes Acquisition Of Clarient 16
Clarient Inc, Key Competitors 19
Clarient Inc, Key Employees 20
Clarient Inc, Subsidiaries 21
List of Figures
Clarient Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Clarient Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Clarient Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Clarient Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Clarient Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Clarient Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Clarient Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Clarient Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8